National Cancer Institute NCI Cancer Bulletin: A Trusted Source for Cancer Research News
May 18, 2010 • Volume 7 / Number 10

Page Options

  • Print This Page
  • Print This Document
  • View Entire Document
  • Email This Document

Cancer.gov Update

Recovery Act Web Site Highlights NCI Clinical Proteomic Technologies for Cancer Initiative

Screenshot of American Recovery and Reinvestment Act at NCI Web page

NCI's American Recovery and Reinvestment Act (ARRA) Web site features new content that highlights the NCI Clinical Proteomic Technologies for Cancer (CPTC) program and describes how Recovery Act funding is helping support an initiative to measure the 250,000 to 1,000,000 proteins in the human body. This pilot project is studying the feasibility and scalability of emerging technologies to accurately measure such large numbers of proteins. By studying the human proteome, researchers hope to learn more about how cancer originates and devise new and better methods for diagnosis, treatment, and prevention.

Learn more about CPTC and other important initiatives here.

< Previous Section  |  Next Section >